REFERENCES
- D. Avner. (2000). Clinical experience with pantoprazole in gastro esophageal reflux disease. Clin. Ther. 22 (10):1170–1185.
- W. Beil, U. Staar, and K. Sewing. Pantoprazole: a novel H+/K+-ATPase inhibitor with an improved pH stability. Eur. J. Pharmacol. 218:265–271.
- S. S. Bhalerao, J. K. Lalla, and M. S. Rane. (2001). Study of processing parameters influencing the properties of diltiazem hydrochloride microspheres. J. Microencapsul. 18:299–307.
- M. Çelik. (1994). Compaction of multiparticulate oral dosage forms: in Multiparticulate Oral Drug Delivery, ed. I. Ghebre-Sellassie., 181–215. New York: Marcel Dekker Inc.
- S. Cheer, A. Prakash, D. Faulds, and H. Lamb. (2003). Pantoprazole—an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. Drugs 63 (1):101–132.
- L. M. Colome, R. P. Raffin, D. S. Jornada, A. R. Pohlmann, and S. S. Guterres. (2007). Pantoprazole-loaded Eudragit blended microparticles: preparation, characterization, in vitro gastro-resistance and in vivo anti-ulcer evaluation. J. Drug Del. Sci. Tech. 17 (2):113–118.
- T. Comoglu, N. Gonul, and T. Baykara. (2003). Preparation and in vitro evaluation of modified release ketoprofen microsponges. Farmaco 58:101–106.
- A. Fitton, and L. Wiseman. (1996). Pantoprazole—a review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 51 (3):460–482.
- C. Hasçiçek, N. Gonul, and N. Erk. (2003). Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: preparation and in vitro characterization. Farmaco 58:11–16.
- B. B. Horoz, M. Kılıçarslan, N. Yüksel, and T. Baykara. (2004). Effect of different dispersing agents on the characteristics of Eudragit microspheres prepared by a solvent evaporation method. J. Microencapsul. 21:191–202.
- H. Huang, and I. Ghebre-Sellassie. (1989). Preparation of microspheres of water-soluble pharmaceuticals. J. Microencapsul. 6:219–225.
- ICH Guideline. (1996). Validation of analytical procedures: text and methodology Q2 (R1).
- M. Kawata, M. Nakamura, S. Goto, and T. Aoyama. (1986). Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen. Chem. Pharm. Bull. 34:2618–2623.
- C. K. Kim, M. J. Kim, and K. H. Oh. (1994). Preparation and evaluation of sustained release microspheres of terbutaline sulfate. Int. J. Pharm. 106:213–219.
- T. Mateovic, B. Kriznar, M. Bogataj, and A. Mrhar. (2002). The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J. Microencapsul. 19:29–36.
- P. B. O'Donell, and J. W. Mc Ginity. (1997). Preparation of microspheres by the solvent evaporation technique. Adv. Drug Deliv. Rev. 28:25–42.
- P. Poole. (2001). Pantoprazole. Am. J. Health Syst. Pharm. 58 (11):999–1008.
- R. P. Raffin, L. M. Colome, A. R. Pohlmann, and S. S. Guterres. (2006). Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Eur. J. Pharm. Biopharm. 63:198–204.
- T. Şengel, C. Hasçiçek, and N. Gönül. (2006). Development and in-vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride. J. Microencapsul. 23 (2):135–152.
- J. M. Shin, and G. Sachs. (2004). Differences in binding properties of two proton pump inhibitors on the gastric H+/K+-ATPase in vivo. Biochem. Pharmacol. 68:2117–2127.
- K. S. Soppimath, A. R. Kulkarni, and T. M. Aminabhavi. (2001). Encapsulation of antihypertensive drugs in cellulose-based matrix microspheres: characterization and release kinetics of microspheres and tableted microspheres. J. Microencapsul. 18:397–409.
- I. Suslu, S. Altinoz, and E. Yildiz. (2003). Determination of pantoprazole in tablet dosage forms by two different spectrophotometric methods. FABAD J. Pharm. Sci. 28:85–92.
- N. K. Varde, and D. W. Pack. (2004). Microspheres for controlled release drug delivery. Expert Opin. Biol. Ther. 4 (1):1–17.
- V. Zupancic, N. Ograjsek, B. Kotar-Jordan, and F. Vrecer. (2005). Physical characterization of pantoprazole sodium hydrates. Int. J. Pharm. 291:59–68.